Sensei Biotherapeutics Statistics Share Statistics Sensei Biotherapeutics has 1.26M
shares outstanding. The number of shares has increased by 0.23%
in one year.
Shares Outstanding 1.26M Shares Change (YoY) 0.23% Shares Change (QoQ) 0.23% Owned by Institutions (%) 7.59% Shares Floating 827.41K Failed to Deliver (FTD) Shares 828 FTD / Avg. Volume 5.34%
Short Selling Information The latest short interest is 7.16K, so 0.57% of the outstanding
shares have been sold short.
Short Interest 7.16K Short % of Shares Out 0.57% Short % of Float 0.85% Short Ratio (days to cover) 1.46
Valuation Ratios The PE ratio is -8.16 and the forward
PE ratio is -0.56.
Sensei Biotherapeutics's PEG ratio is
4.98.
PE Ratio -8.16 Forward PE -0.56 PS Ratio 0 Forward PS n/a PB Ratio 6.41 P/FCF Ratio -9.92 PEG Ratio 4.98
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sensei Biotherapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.7,
with a Debt / Equity ratio of 0.1.
Current Ratio 7.7 Quick Ratio 7.7 Debt / Equity 0.1 Debt / EBITDA -0.12 Debt / FCF -0.15 Interest Coverage -362.38
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.15M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -38.94% in the
last 52 weeks. The beta is 0.26, so Sensei Biotherapeutics's
price volatility has been higher than the market average.
Beta 0.26 52-Week Price Change -38.94% 50-Day Moving Average 7.7 200-Day Moving Average 8.76 Relative Strength Index (RSI) 48.51 Average Volume (20 Days) 15,500
Income Statement
Revenue n/a Gross Profit n/a Operating Income -32.61M Net Income -30.16M EBITDA -32.61M EBIT -30.25M Earnings Per Share (EPS) -1.2
Full Income Statement Balance Sheet The company has 9.99M in cash and 3.85M in
debt, giving a net cash position of 6.15M.
Cash & Cash Equivalents 9.99M Total Debt 3.85M Net Cash 6.15M Retained Earnings -262.05M Total Assets 31.78M Working Capital 25.7M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -24.67M
and capital expenditures -146K, giving a free cash flow of -24.82M.
Operating Cash Flow -24.67M Capital Expenditures -146K Free Cash Flow -24.82M FCF Per Share -0.99
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SNSE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SNSE is $55,
which is 635.3% higher than the current price. The consensus rating is "Strong Buy".
Price Target $55 Price Target Difference 635.3% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 17, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Jun 17, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -12.58 Piotroski F-Score 2
